Evotec SE (EVO) Free Cash Flow (2009 - 2026)
Evotec SE's (EVO) quarterly Free Cash Flow came in at $289174.2 in Q1 2026, up 102.02% year-over-year from $143141.4 in Q1 2025, and down 99.23% quarter-over-quarter from $37.7 million in Q4 2025.
Analysis
Evotec SE (EVO) Free Cash Flow (2009 - 2026) Analysis & Trends
Evotec SE has disclosed Free Cash Flow across 9 years of filings, most recently posting $289174.2 for Q1 2026.
- In Q1 2026, Free Cash Flow rose 102.02% year-over-year to $289174.2; the TTM figure through Mar 2026 stood at $34.7 million (down 75.41% YoY), while the FY2025 annual figure was $71.6 million, down 51.25% from the prior year.
- Free Cash Flow came in at $289174.2 for Q1 2026 at Evotec SE, down from $37.7 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $250.8 million in Q4 2023 to a low of -$86.2 million in Q3 2022.
- Average Free Cash Flow over 5 years is $58.9 million, with a median of $44.9 million recorded in 2025.
- The largest YoY upside for Free Cash Flow was 255676.65% in 2022 against a maximum downside of 973.0% in 2022.
- Over 5 years, Free Cash Flow stood at $153.7 million in 2022, then surged by 63.14% to $250.8 million in 2023, then plunged by 61.9% to $95.6 million in 2024, then tumbled by 60.55% to $37.7 million in 2025, then tumbled by 99.23% to $289174.2 in 2026.
- Per Business Quant data, the three most recent Free Cash Flow figures were $289174.2 in Q1 2026, $37.7 million in Q4 2025, and -$55.4 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | 360.00 Mn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 138.10 Mn |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | 148.62 Mn |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | 323.69 Mn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | 19.90 Mn |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | -46.89 Mn |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | -2.24 Mn |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | -1.75 Mn |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | -3.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 289,174.18 |
| Dec 31, 2025 | 37.70 Mn |
| Sep 30, 2025 | -55.35 Mn |
| Jun 30, 2025 | 52.06 Mn |
| Mar 31, 2025 | -14.32 Mn |
| Dec 31, 2024 | 95.55 Mn |
| Sep 30, 2024 | 76.19 Mn |
| Jun 30, 2024 | -16.33 Mn |
| Mar 31, 2024 | -8.63 Mn |
| Dec 31, 2023 | 250.82 Mn |
| Jun 30, 2023 | 153.47 Mn |
| Mar 31, 2023 | -45.60 Mn |
| Dec 31, 2022 | 153.74 Mn |
| Sep 30, 2022 | -86.21 Mn |
| Jun 30, 2022 | 229.89 Mn |
| Mar 31, 2022 | 119.57 Mn |
| Dec 31, 2021 | 324.69 Mn |
| Sep 30, 2021 | -8.03 Mn |
| Jun 30, 2021 | -37.94 Mn |
| Mar 31, 2021 | 46,748.89 |